Taking Control Of Your Diabetes® - The Podcast!

Dr. Steve Edelman and Dr. Jeremy Pettus discuss how GLP-1 medications have evolved and where they may be headed next. They look back at the progression from early twice-daily injections to once-weekly therapies and explain how the role of GLP-1s has expanded from managing glucose to supporting weight management, cardiovascular health, kidney health, and other areas of metabolic health.

The conversation explores newer oral GLP-1 options and what taking a pill instead of an injection could mean for people who prefer that option. Dr. Edelman and Dr. Pettus also discuss the next generation of therapies that combine GLP-1 with hormones such as glucagon and amylin. They explain why researchers are combining these different hormones, how they may affect weight and glucose, and why getting to the highest possible dose isn’t necessarily the goal for everyone.

They also address some of the practical questions that come with taking a GLP-1, including side effects, cost, insurance coverage, and whether these medications need to be taken long term. The discussion covers nausea and other GI side effects, concerns about losing muscle and lean mass during significant weight loss, and why getting enough protein and staying physically active can be important. They also explain what can happen when GLP-1 therapy is stopped, including the possibility of regaining weight.

Finally, Dr. Edelman and Dr. Pettus discuss what GLP-1 medications could mean for people living with type 1 diabetes. They share their clinical experience using these medications in people with type 1 diabetes for other indications and discuss ongoing research looking at their potential effects on weight, insulin needs, A1C, and glucose variability. They also look at how future approvals could affect insurance coverage and what continued innovation may mean for people living with diabetes.

★ Support this podcast ★

What if you could take your basal insulin once a week instead of every day? Once-weekly basal insulin has arrived, offering a new approach that could make insulin therapy simpler while providing glucose control comparable to daily basal insulin.

In this episode, Dr. Steve Edelman is joined by Dr. Athena Philis-Tsimikas, a leading diabetes researcher who has been directly involved in clinical trials of once-weekly basal insulins. Together, they explain how these ultra-long-acting insulins work, how a single injection can provide steady background insulin throughout an entire week, and what studies have shown when once-weekly insulin is compared with traditional daily basal insulin.

The conversation gets practical with how once-weekly insulin is started, adjusted, and switched from daily basal insulin. Dr. Edelman and Dr. Philis-Tsimikas discuss the dosage differences with once-weekly basal insulin, how concentrated insulin keeps the actual injection volume small, and how fasting glucose can help guide dose adjustments. They also discuss what happens if you miss a dose and why reaching a steady state is an important part of understanding how these longer-acting insulins work.

They also dive into the clinical trial results, including A1C, time in range, and hypoglycemia. In studies of people living with type 2 diabetes, once-weekly basal insulin provided similar A1C lowering to daily basal insulin without an increase in hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, where studies found higher rates of hypoglycemia with weekly basal insulin, and what that means for its use in the United States.

Finally, Dr. Edelman and Dr. Philis-Tsimikas look at how once-weekly insulin could make diabetes management easier. Going from seven basal injections a week to just one could help reduce some of the daily burden of diabetes and make it easier to consistently take your insulin. They also explore using weekly insulin alongside GLP-1 medications, potential combination therapies, cost and access, and what we still need to learn as these newer insulins move from clinical trials into everyday diabetes care.

Key Topics:

• How once-weekly basal insulin works
• Once-weekly vs. daily basal insulin
• Starting, dosing, and adjusting weekly insulin
• Why weekly insulin doses may look surprisingly large
• A1C, time in range, and hypoglycemia results
• What to do if you miss a weekly dose
• Once-weekly insulin in type 1 vs. type 2 diabetes
• Who may benefit from once-weekly insulin?
• Reducing the burden of daily injections
• Using once-weekly insulin with GLP-1 medications
• Future insulin and GLP-1 combination therapies
• Cost, access, and real-world considerations
• What the future of basal insulin could look like

This episode was supported by Lilly.

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

Managing type 2 diabetes can change over time, but having the right information for your patients can make those changes feel a lot more manageable. CGM can help your patients see what’s happening with their blood sugar and guide what comes next.

In this episode of the TCOYD Podcast, Dr. Steve Edelman and Dr. Jeremy Pettus discuss how continuous glucose monitoring is changing the way type 2 diabetes is managed for your patients, especially as treatment needs evolve over time. They explain why type 2 diabetes can progress from lifestyle changes and oral medications to GLP-1 therapies and insulin, and why needing insulin isn’t a personal failure. They also explore how seeing glucose data in real time can help your patients better understand how meals, exercise, medications, and insulin affect their glucose throughout the day.
The conversation gets practical with how CGM can help guide your patients’ transition to basal insulin, make insulin adjustments easier and safer, and identify when mealtime insulin may be needed. Dr. Edelman and Dr. Pettus explain what overnight glucose patterns can tell you about your patients’ basal insulin dose, how to recognize post-meal spikes, and why starting mealtime insulin doesn’t necessarily mean adding injections at every meal for your patients. They also discuss newer basal insulins, avoiding too much basal insulin, and how automated insulin delivery systems may fit into the future of type 2 diabetes management.
Ultimately, CGM gives your patients living with type 2 diabetes more than glucose numbers. It provides feedback that can help them recognize patterns, see how their treatment is working, and work with their healthcare team to make more informed adjustments as their diabetes management needs change.

Key Topics:

• Why type 2 diabetes treatment needs can change over time
• How insulin resistance and declining insulin production affect glucose management
• Why needing insulin is not a personal failure
• How CGM use is expanding in type 2 diabetes
• Using CGM with lifestyle changes, oral medications, GLP-1 therapies, and insulin
• What time in range, GMI, and glucose variability can tell you
• How CGM can help determine when basal insulin may be needed
• Using overnight glucose patterns to adjust basal insulin
• Why insulin titration matters more than the initial starting dose
• How CGM can make insulin adjustments easier and safer
• When mealtime insulin may be needed
• Why mealtime insulin doesn’t always have to be taken with every meal
• How to recognize and avoid too much basal insulin
• The benefits of newer long-acting basal insulins
• When patients with type 2 diabetes may want to consider an insulin pump or automated insulin delivery system
• How real-time glucose feedback can help people take a more active role in their diabetes management

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

Chronic kidney disease (CKD) is one of the most common complications of diabetes, but here’s the tricky part: you can have it for years without feeling any symptoms. The good news? Kidney disease can often be detected early, and with the right screening, treatments, and lifestyle changes, its progression can be dramatically slowed.

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by nephrologist Dr. Bethany Karl to break down what everyone with diabetes should know about kidney health. Dr. E also steps into the patient seat to share his own experience living with chronic kidney disease, from discovering it without symptoms to navigating kidney tests and newer treatments. Together, they explain the two simple tests that can uncover kidney problems, why blood pressure and cardiovascular health matter, and how today’s growing toolbox of medications is giving people with diabetic kidney disease more reasons for hope.

Key Topics:

• Why chronic kidney disease is often a “silent” complication of diabetes
• How diabetes can affect the kidneys over time
• Dr. Edelman’s personal experience with diabetic kidney disease
• The two important kidney tests: eGFR and UACR
• Why urine protein can be an important early warning sign
• How often people with diabetes should have their kidneys screened
• The connection between glucose, blood pressure, cholesterol, heart health, and kidney health
• Lifestyle considerations for protecting kidney function
• Medications that can help slow the progression of diabetic kidney disease
• Newer kidney-protective therapies and why there is more reason for optimism today

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

Hot flashes, blood sugar swings, brain fog... is it menopause, diabetes, or both?

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by renowned menopause expert Dr. Cindy Stuenkel, endocrinologist and Professor Emerita at UC San Diego, for an insightful conversation about how menopause affects women living with diabetes. Together, they explain why menopause is much more than a normal stage of aging. It's a major metabolic transition that can influence blood sugar management, insulin resistance, heart health, sleep, mood, and overall quality of life.

The conversation explores what actually happens during perimenopause, menopause, and postmenopause, why hormonal fluctuations can make glucose management more challenging, and how continuous glucose monitoring can help distinguish hot flashes from hypoglycemia. Dr. Edelman and Dr. Stuenkel also discuss the latest evidence on hormone replacement therapy, newer non-hormonal treatment options, the importance of protecting heart health, and practical strategies to help women navigate this stage of life with greater confidence. Whether you're living with type 1 or type 2 diabetes, approaching menopause, currently experiencing it, or supporting someone who is, this episode provides practical guidance and evidence-based information to help you feel more prepared.

Key Topics:

• What is perimenopause, menopause, and postmenopause?
• How hormonal changes affect blood sugar and insulin resistance
• Why menopause can increase glucose variability in women with diabetes
• The difference between hot flashes and hypoglycemia
• How continuous glucose monitoring can help during menopause
• Metabolic changes that occur during the menopause transition
• Why cardiovascular risk increases after menopause
• The connection between menopause, weight gain, and abdominal fat
• GLP-1 medications and menopause
• The latest recommendations on hormone replacement therapy
• New non-hormonal treatments for hot flashes
• Sleep, mood, brain fog, and quality of life during menopause
• Heart health strategies for women living with diabetes
• How partners can better support someone going through menopause
• Trusted menopause resources and when to seek medical care

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

Have you or someone you know been diagnosed with type 2 diabetes, only to discover later it was actually type 1? You're not alone.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Dr. Schaefer Boeder, endocrinologist, Medical Director of Paradigm Research, Associate Professor at UCSD, for an eye-opening discussion about LADA (Latent Autoimmune Diabetes in Adults)—one of the most commonly misdiagnosed conditions in diabetes. Together, they explain why so many adults are initially misdiagnosed with type 2 diabetes despite the warning signs that should raise suspicion for LADA, and why getting the correct diagnosis can dramatically change treatment and long-term outcomes.

The conversation explores how LADA differs from both classic type 1 and type 2 diabetes, why the autoimmune process develops more slowly, and when antibody testing should be considered. Dr. Edelman and Dr. Boeder also discuss the importance of preserving beta cell function, the role of continuous glucose monitoring, advances in disease-modifying therapies, and why there has never been a more exciting time for research in adults who developed type 1 diabetes later in life. Whether you've been diagnosed with LADA, care for someone who has, or simply want to better understand adult-onset autoimmune diabetes, this episode provides practical guidance and hope for more accurate diagnoses in the future.

Key Topics:

• What is LADA (Latent Autoimmune Diabetes in Adults)?
• Why LADA is so often mistaken for type 2 diabetes
• Common signs that may point to a misdiagnosis
• How LADA differs from classic type 1 and type 2 diabetes
• Why many adults don't fit the "typical" diabetes profile
• Autoantibody testing and when it should be considered
• The role of GAD antibodies and C-peptide testing
• Why preserving beta cell function matters
• Preventing diabetic ketoacidosis (DKA) through earlier diagnosis
• How continuous glucose monitoring can ease the transition to insulin
• Current treatment approaches for adults with LADA
• The latest research on disease-modifying therapies and preserving insulin production
• Screening resources, clinical trials, and where the future of LADA research is headed

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by Dr. Shara Bialo, Senior Medical Director of Type 1 Diabetes Immunology at Sanofi, pediatric endocrinologist, and person living with type 1 diabetes, for an in-depth discussion about what happens before type 1 diabetes is diagnosed. Together, they explore the autoimmune process that begins months or even years before symptoms appear, why early detection matters, and how screening is changing the future of type 1 diabetes care.

Dr. Bialo shares her personal diagnosis story, discusses common misconceptions about what causes type 1 diabetes, and explains the three stages of the disease. The conversation also covers who should be screened, how diabetes autoantibody testing works, the benefits of preserving beta cell function, and why identifying people before they develop symptoms can lead to better long-term outcomes and fewer cases of diabetic ketoacidosis (DKA). Whether you have type 1 diabetes, have a family member at risk, or simply want to better understand the latest advances in prevention and early detection, this episode provides valuable insights into one of the fastest-moving areas of diabetes research.

Key Topics:

• Dr. Shara Bialo's personal journey living with type 1 diabetes
• Why type 1 diabetes is an autoimmune disease, not simply a blood sugar problem
• The role of genetics, viral infections, and the immune system
• Understanding the three stages of type 1 diabetes
• Why most people diagnosed with type 1 diabetes have no family history
• Adult-onset type 1 diabetes and why it is often mistaken for type 2 diabetes
• What diabetes autoantibodies are and how screening works
• Who should consider screening for type 1 diabetes
• Available screening options, including blood tests and home screening kits
• The emotional challenges families face when considering screening
• The importance of preventing diabetic ketoacidosis through early detection
• Why preserving beta cell function can improve long-term outcomes
• Italy's national screening program and the future of population-wide screening
• Resources available through http://screenfortype1.com

This content was produced with support from Sanofi and http://screenfortype1.com/.

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes.

Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal.

Whether you’re the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives.

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip’s dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.

The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.
Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.

Key Topics
• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes
• The design and results of the INHALE-1 pediatric clinical trial
• Patient satisfaction and quality-of-life outcomes from the study
• The challenges of pre-bolusing and mealtime insulin management in children and teens
• How inhaled insulin compares to traditional mealtime injections
• Dosing strategies, cartridge sizes, and insulin conversion considerations
• Using Afrezza for corrections, meals, and post-meal dosing
• The role of continuous glucose monitoring (CGM) when using inhaled insulin
• Safety findings, lung-function monitoring, and cough management
• Who may be a good candidate for Afrezza—and who may not be
• Benefits for active children, athletes, and those participating in sports
• Social situations, injection avoidance, and reducing the burden of diabetes management
• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems
• The importance of having more treatment options to individualize diabetes care

Supported by an unrestricted educational grant from MannKind Corporation

Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/Blog: https://tcoyd.org/blog/Podcast: https://tcoydthepodcast.transistor.fm/Instagram: / tcoydFacebook: / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

In this episode of the TCOYD Podcast, Drs. Edelman and Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to discuss inhaled insulin in children and its place in pediatric practice.

The conversation centers on the recent approval of Afrezza down to age six and what INHALE-1 actually demonstrated. Dr. Wood walks through the trial design, the A1C analysis, the FEV1 and pulmonary safety data, the weight and BMI findings, and the practical mechanics of dosing in a pediatric population. Rather than framing it as a replacement for injections or automated insulin delivery (AID), the discussion focuses on where this option fits, from the needle-averse newly diagnosed patient, to the teen trying to bolus discreetly during a 20-minute lunch period.

Drs. Edelman, Pettus, and Wood also get into the clinical realities that shape real-world use: the 2:1 to 3:1 conversion versus subcutaneous insulin, the set-dose cartridges and how they reframe carb counting, a refined titration approach, side effects, and how inhaled insulin can be layered alongside pumps and AID. For a population where mealtime bolusing remains one of the most stubborn unmet needs, it is a grounded look at a new tool and the patients it may help most.

Key Topics

• The recent approval of inhaled insulin for children as young as six
• How the INHALE-1 pediatric trial was designed
• A1C results and what the primary endpoint analysis showed
• Continuous glucose monitor (CGM) metrics across the two groups
• Lung-function (FEV1) monitoring and pediatric safety
• Weight and body mass index (BMI) findings
• Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D)
• The set-dose cartridge approach and how it reframes meal sizes
• A real-world titration method for inhaled insulin
• Managing cough and other practical considerations
• Needle phobia and the kids who struggle most with injections
• Using inhaled insulin alongside automated insulin delivery (AID) systems
• What's coming next, including a smaller cartridge dose and a new-onset trial

This episode is supported by an unrestricted educational grant from MannKind Corporation.

Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/Blog: https://tcoyd.org/blog/Podcast: https://tcoydthepodcast.transistor.fm/Instagram: / tcoydFacebook: / tcoyd
Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life?

In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they’re seeing in real-world diabetes care.

The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person’s lifestyle, preferences, and goals.

Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible.

Key Topics
• Choosing the right insulin pump and CGM
• Tubed vs. tubeless pump systems
• How lifestyle and personal preference shape technology choices
• The latest updates in automated insulin delivery systems
• Dexcom G7 10-day vs. 15-day sensors
• Abbott’s dual glucose and ketone sensor technology
• Medtronic’s newest technology developments
• Real-world conversations patients have about wearing devices
• Continuous ketone monitoring and DKA prevention
• The future of fully closed loop systems
• Why compatibility between pumps and CGMs matters
• Technology options for people with type 2 diabetes
• Where diabetes technology may be headed next

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What if something was going on with your health and you didn’t feel any symptoms at all? Could it be metabolic dysfunction-associated steatohepatitis (MASH)? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus talk about fatty liver and MASH, a condition that can develop quietly but still has a real impact over time. They’re joined by patient advocate Manuel Oliver, who shares his experience after being diagnosed and what helped him turn things around.

They explain why fatty liver is so common, especially in people with metabolic conditions, and why it often goes unnoticed. The conversation also highlights how things can change over time, even when you feel okay, and why routine checkups matter.

Manuel shares what it was like to hear his diagnosis, how it affected him, and the steps he took to improve his health. You’ll also hear how care has evolved, including better ways to detect liver disease and more options to support treatment alongside lifestyle changes.

The message is simple: this condition can be serious, but there are ways to manage it, and taking action can make a meaningful difference.

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What does it really mean to be “gluten-free” and how do you know if it’s something you actually need?In this episode, Dr. Steve Edelman sits down with registered dietitian EA Stewart (aka The Spicy RD) to talk through the difference between celiac disease and gluten sensitivity, and why that distinction matters. They explain how celiac disease develops, why it’s often missed, and how it connects to other autoimmune conditions like type 1 diabetes.

This conversation helps make sense of a topic that can feel confusing. Dr. E and EA walk through symptoms that go beyond digestion, the importance of getting tested the right way, and what it means to truly follow a gluten-free diet.
They also talk about the day-to-day side of things—how to approach food, avoid cross-contamination, and build a way of eating that works in real life.
The main takeaway: not everyone needs to avoid gluten, but if you do, understanding the reason behind it can make it a lot more manageable

Key Topics
• What celiac disease is and how it differs from gluten sensitivity
• The role of genetics, triggers, and gluten exposure
• Why celiac disease is often undiagnosed
• Common and less obvious symptoms
• The connection between celiac disease and type 1 diabetes
• How to properly test for celiac disease
• Why you need to be eating gluten before testing
• What a gluten-free diet actually looks like
• Naturally gluten-free foods and better alternatives
• Hidden sources of gluten in everyday foods
• Cross-contamination and why it matters
• Nutrient deficiencies and when supplements may help
• Tips for eating out and traveling

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What if a type 2 diabetes diagnosis could be the start of taking better care of your health—not the end of it?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share their top 10 tips for people newly diagnosed with type 2 diabetes, with a focus on helping you feel informed, supported, and encouraged. They talk about why this diagnosis is not a personal failure, how much of it is connected to genetics and metabolism, and why early understanding can make a meaningful difference.

The conversation is grounded, hopeful, and focused on what’s possible. Steve and Jeremy walk through simple, realistic steps that can help you feel more in control—without pressure to be perfect. They cover everything from understanding how your body works to building habits that fit into your everyday life, along with the growing number of tools and treatments that can support you along the way.

The takeaway is clear: this diagnosis can feel overwhelming at first, but it can also be a turning point. With time, support, and the right approach, you can improve your health and continue living a full, active life.

Key Topics
• Why type 2 diabetes is not your fault
• Understanding insulin resistance and disease progression
• Why early action matters
• Focusing on weight with realistic expectations
• The role of GLP-1 medications in early treatment
• Exercise and movement as part of daily life
• Learning how food affects your body
• Using blood sugar monitoring in a practical way
• Taking medications consistently
• Protecting your heart early
• The importance of routine screenings and labs
• Building a strong and supportive care team

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What does someone really need to know in the first days and weeks after a type 1 diabetes diagnosis?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share the “starter kit” they wish every newly diagnosed person and family had from the very beginning. Both diagnosed with type 1 diabetes at age 15, Steve and Jeremy reflect on what has changed since their own diagnoses and walk through the practical advice, emotional reassurance, and foundational education that can make this transition a little less overwhelming.

The conversation covers everything from the normal emotional reaction to a diagnosis, to the importance of early diabetes education, getting started with insulin, using CGM as soon as possible, and setting realistic blood sugar goals. They also talk about the honeymoon phase, how to keep doing the things you love, why support systems matter, how to find the right provider, and what newly diagnosed families should know about clinical trials and preserving beta cell function.

This episode is a reminder that while a new diagnosis can feel like your world has been turned upside down, people with type 1 diabetes can live long, healthy, full lives—and that no one has to figure it all out alone.

Key Topics

• Why it’s okay to feel overwhelmed after diagnosis

• The importance of diabetes education right away

• Understanding the honeymoon phase

• Basal and bolus insulin basics

• Why CGM should be started early

• Realistic A1C and time-in-range goals

• Keeping up with the things you love

• Involving family, friends, and support networks

• Finding the right diabetes provider

• Considering clinical trials after diagnosis

• Food, carb counting, and keeping things simple

• Staying positive and looking ahead

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

Are you getting the most out of the diabetes technology you use every day and do you know what’s coming next?

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with diabetes tech expert Justin Eastzer, creator of Diabetech, who is also living with type 1 diabetes, for a conversation about the steadily growing and expanding world of diabetes technology. They talk about how CGMs, automated insulin delivery systems, connected apps, and wearable displays are continuing to improve the way people with type 1 diabetes manage glucose in daily life.

Justin shares his diagnosis story, including being initially treated for type 2 diabetes before learning he had type 1, and how the online diabetes community helped him find the right answers. That experience led him to build a platform dedicated to reviewing devices, following industry developments, and helping people better understand the technology available today.

The discussion explores the current landscape of automated insulin delivery systems, practical differences between pumps, and the growing ecosystem of apps, displays, and data tools that allow people to interact with their glucose data in real time. They also look ahead at what’s coming next in diabetes tech, including new pump designs, smarter algorithms, improved connectivity, and continued efforts to reduce the day-to-day workload of living with type 1 diabetes.

Key Topics
• Why many people only use part of their diabetes tech’s capabilities
• Justin’s journey to a type 1 diabetes diagnosis
• Making pumps, CGMs, and apps work in everyday life
• Comparing automated insulin delivery systems
• Tubed vs. tubeless pump considerations
• The importance of optimizing personal settings
• Progress over perfection with time in range
• Reducing diabetes burnout through technology
• Helpful apps, displays, and tech hacks
• Where diabetes technology is heading next

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What does it really look like to grow older with type 1 diabetes today?

The good news is people with diabetes are now living longer than ever! In this episode, Dr. Steve Edelman is joined by diabetes advocate Joanne Milo and endocrinologist Dr. Athena Tsimikas to talk about the realities of aging with type 1. They share how expectations have changed over time, why more people are now living long lives with diabetes, and what it takes to stay safe, independent, and supported through the aging process. The conversation covers changing insulin needs, screening for vision, hearing, and cognitive health, the role of technology, and the importance of community and care partners.

They also discuss the emotional side of aging with diabetes, including the need to feel heard, understood, and safe while continuing to live a full and meaningful life.

Key Topics
• Living longer with type 1: how expectations have changed
• Changing insulin sensitivity, muscle mass, and dosing over time
• Preventing falls: vision, neuropathy, and mobility considerations
• Cognitive health and why screening matters
• Technology in older adults: CGM and hybrid closed-loop benefits
• Medication considerations for heart and kidney protection
• The role of care partners and support systems
• Emotional health: fear, independence, and being understood
• Staying active, social, and engaged while aging with diabetes
• Advocacy and preparing for the future

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What does it take to safely manage type 1 diabetes while flying a commercial jet?

In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman talk with Quinton Weiskittel, a commercial pilot living with type 1 diabetes. Quinton shares what it was like to be diagnosed mid-career, how FAA rules have changed, and the real-world routines he uses to stay steady through long flights, time zones, busy airports, and long stretches of sitting.

They also cover what the FAA requires for certification, how Quinton uses CGM data and smart “buffer” strategies to prevent lows, and why he’s chosen MDI over pump therapy while flying.

Key Topics

• Being diagnosed with diabetes mid-career: the moment everything changed
• FAA rules on pilots with diabetes and the path back to the cockpit
• CGM targets, reporting requirements, and medical follow-ups as a pilot with diabetes
• Preventing lows during flights: alerts, trends, and planning ahead
• Food choices and low-carb strategies while flying a plane
• What coworkers need to know (CGM alarms, injections, and professionalism)
• Travel tips for diabetes: airports,travel lulls and wait time, and insulin logistics
• Pump therapy in the air: pressure concerns and practical tradeoffs
• Advocacy and finding the right endocrinology support
• Life perspective: staying grounded while chasing big goals

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What exactly is inflammation, and how do you know if it's affecting your health? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Dr. Jennie Luna, an endocrinologist specializing in obesity medicine and nutrition, to demystify inflammation and its connection to diabetes and metabolic health.

Together, they explore the difference between acute and chronic inflammation, why chronic inflammation often goes unnoticed despite affecting nearly every organ system, and how it drives conditions like insulin resistance, fatty liver disease, and chronic kidney disease. Dr. Luna breaks down the warning signs—fatigue, brain fog, difficulty sleeping, and weight gain—and explains why these symptoms are so easy to miss.

The conversation shifts to actionable strategies you can implement today. From anti-inflammatory eating patterns and time-restricted eating to managing stress and prioritizing sleep, this episode focuses on practical, realistic changes that don't require perfection or meal prep mastery.

Key Topics

• Understanding Inflammation: The difference between acute and chronic inflammation and why chronic inflammation silently impacts metabolic health.
• Signs You Might Be Inflamed: Recognizing vague symptoms like fatigue, mental fog, and disrupted sleep that often go undiagnosed.
• Inflammation and Diabetes: How insulin resistance, high blood sugar, and inflammation create a vicious cycle—and how to break it.
• Anti-Inflammatory Eating Made Simple: Practical food strategies including protein-first meals, time-window eating, and budget-friendly swaps.
• The Fast Food Reality: Honest talk about convenience eating and how to make better choices when time is tight.
• Beyond Diet: Why sleep quality, stress management, and even 10-minute post-meal walks have powerful anti-inflammatory effects.
• GLP-1s and Inflammation: Emerging research showing these medications may reduce inflammation independent of weight loss.
• The Bottom Line: Why small, sustainable changes—not perfection—are the key to reducing inflammation and improving overall health.

[00:00:23] - Introduction: What is inflammation?

[00:00:45] - Welcome to the Taking Control of Your Diabetes Podcast

[00:01:23] - Special Guest: Dr. Jennie Luna (Endocrinology & Obesity Medicine)

[00:02:55] - Acute vs. Chronic Inflammation

[00:03:40] - The "Stingray" Incident: A Lesson in Acute Inflammation

[00:04:07] - Pro-Tip: How to do the "Stingray Shuffle"

[00:05:05] - Identifying the Signs and Symptoms of Chronic Inflammation

[00:07:09] - The Vicious Cycle: Inflammation and Insulin Resistance

[00:08:13] - Metabolic Syndrome: Heart, Liver, and Kidney Health

[00:09:24] - Why Weight Loss is the Ultimate Anti-Inflammatory

[00:10:41] - Silent Triggers: Stress, Lack of Sleep, and Diet

[00:12:33] - High-Yield Diet Tips: The "Protein First" Rule

[00:13:28] - Time-Window Eating and Intermittent Fasting

[00:15:29] - Is Healthy Eating Actually More Expensive?

[00:17:25] - Realistic Habit Changes and Success Markers

[00:19:53] - The Great Egg Debate: Protein vs. Cholesterol

[00:21:58] - Practical Tips: Meal Prep and Chia Seed Pudding

[00:25:35] - The Anti-Inflammatory Future: GLP-1s and New Research

[00:27:34] - Stress Management and the Dopamine "Reward Circuit"

[00:29:07] - The Link Between Sleep Apnea and Inflammation

[00:30:07] - Sleep Hygiene: Removing Blue Light and Doom Scrolling

[00:31:38] - The Power of Exercise and the 10-Minute Post-Meal Walk

[00:32:17] - Conclusion and Final Takeaways

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★

What new advancements are actually coming in diabetes care in 2026 and what’s in store in the near future? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus both take a look at the diabetes treatments and technologies they believe are most likely to arrive in 2026.

Together, they walk through emerging therapies for both type 1 and type 2 diabetes, focusing on developments that are no longer theoretical but actively moving through late-stage trials and regulatory review. The conversation covers disease-modifying treatments, next-generation medications, and technology advances that could meaningfully change daily diabetes management.

Key Topics:

• Disease-Modifying Therapies for T1D: Preserving beta cell function after T1D diagnosis and why this represents a major shift in treatment goals.
• New Medications for Type 2 Diabetes: Oral GLP-1s, dual- and triple-agonist therapies, and what they may offer beyond current options.
• GLP-1s in Type 1 Diabetes: Where the research stands, off-label use today, and what future approvals could look like.
• Once-Weekly Basal Insulin: Why it’s promising for type 2 diabetes and who it’s best suited for.
• Inhaled Insulin Updates: New dosing guidance and expanded use cases.
• Continuous Ketone Monitoring: How this technology could improve safety and open doors for additional therapies in T1D.
• Cure-Oriented Research: Stem cell and gene therapy approaches that aim to restore insulin production.
• The Big Picture in 2026: Why 2026 represents real momentum — and what it could mean for access, outcomes, and quality of life.

We also created an article on this topic - READ IT HERE!

✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.

More diabetes resources:
Website: https://tcoyd.org/
Blog: https://tcoyd.org/blog/
Podcast: https://tcoydthepodcast.transistor.fm/
Instagram: / tcoyd
Facebook: / tcoyd

Stay connected! Sign up for our monthly newsletter here!
Support TCOYD's educational programs: https://tcoyd.org/donate

★ Support this podcast ★